Skip to Main Content

Author Details

Ben Ho Park
Vanderbilt University Medical Center
1990
170
53
PMIDPaper TitleJournal TitlePublished Year
36585450Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis.Nat Cancer2023
36585450Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis.Nat Cancer2023
34734967Implications of Selection Bias Due to Delayed Study Entry in Clinical Genomic Studies.JAMA Oncol2022
36229464Single cell analysis of cribriform prostate cancer reveals cell intrinsic and tumor microenvironmental pathways of aggressive disease.Nat Commun2022
35259269Targeting Metabolic Adaptations in the Breast Cancer-Liver Metastatic Niche Using Dietary Approaches to Improve Endocrine Therapy Efficacy.Mol Cancer Res2022
34734967Implications of Selection Bias Due to Delayed Study Entry in Clinical Genomic Studies.JAMA Oncol2022
35192403A Scalable Quality Assurance Process for Curating Oncology Electronic Health Records: The Project GENIE Biopharma Collaborative Approach.JCO Clin Cancer Inform2022
35025760Single-cell analysis of somatic mutation burden in mammary epithelial cells of pathogenic BRCA1/2 mutation carriers.J Clin Invest2022
35186194<i>NOTCH1</i> PEST domain variants are responsive to standard of care treatments despite distinct transformative properties in a breast cancer model.Oncotarget2022
35078818Hotspot ESR1 Mutations Are Multimodal and Contextual Modulators of Breast Cancer Metastasis.Cancer Res2022
35074264Olaparib Use in Patients With Metastatic Breast Cancer Harboring Somatic BRCA1/2 Mutations or Mutations in Non-BRCA1/2, DNA Damage Repair Genes.Clin Breast Cancer2022
36229464Single cell analysis of cribriform prostate cancer reveals cell intrinsic and tumor microenvironmental pathways of aggressive disease.Nat Commun2022
35192403A Scalable Quality Assurance Process for Curating Oncology Electronic Health Records: The Project GENIE Biopharma Collaborative Approach.JCO Clin Cancer Inform2022
35074264Olaparib Use in Patients With Metastatic Breast Cancer Harboring Somatic BRCA1/2 Mutations or Mutations in Non-BRCA1/2, DNA Damage Repair Genes.Clin Breast Cancer2022
35186194<i>NOTCH1</i> PEST domain variants are responsive to standard of care treatments despite distinct transformative properties in a breast cancer model.Oncotarget2022
35025760Single-cell analysis of somatic mutation burden in mammary epithelial cells of pathogenic BRCA1/2 mutation carriers.J Clin Invest2022
35078818Hotspot ESR1 Mutations Are Multimodal and Contextual Modulators of Breast Cancer Metastasis.Cancer Res2022
35259269Targeting Metabolic Adaptations in the Breast Cancer-Liver Metastatic Niche Using Dietary Approaches to Improve Endocrine Therapy Efficacy.Mol Cancer Res2022
34253820Selective therapeutic strategy for p53-deficient cancer by targeting dysregulation in DNA repair.Commun Biol2021
34290053A small-molecule activator of the unfolded protein response eradicates human breast tumors in mice.Sci Transl Med2021
34283806Systemic inhibition of PTPN22 augments anticancer immunity.J Clin Invest2021
33795350Inhibition of Human Uracil DNA Glycosylase Sensitizes a Large Fraction of Colorectal Cancer Cells to 5-Fluorodeoxyuridine and Raltitrexed but Not Fluorouracil.Mol Pharmacol2021
33536276Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer.Clin Cancer Res2021
33739964Circulating tumor DNA in early-stage breast cancer: new directions and potential clinical applications.Clin Adv Hematol Oncol2021
33529175Hierarchical tumor heterogeneity mediated by cell contact between distinct genetic subclones.J Clin Invest2021
33999652Updated Results of TBCRC026: Phase II Trial Correlating Standardized Uptake Value With Pathological Complete Response to Pertuzumab and Trastuzumab in Breast Cancer.J Clin Oncol2021
34040179The breast is yet to come: current and future utility of circulating tumour DNA in breast cancer.Br J Cancer2021
34092112Randomized Phase III Postoperative Trial of Platinum-Based Chemotherapy Versus Capecitabine in Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy: ECOG-ACRIN EA1131.J Clin Oncol2021
34253820Selective therapeutic strategy for p53-deficient cancer by targeting dysregulation in DNA repair.Commun Biol2021
34390291Framework for Implementing and Tracking a Molecular Tumor Board at a National Cancer Institute-Designated Comprehensive Cancer Center.Oncologist2021
34470810Correction: Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer.Clin Cancer Res2021
33795350Inhibition of Human Uracil DNA Glycosylase Sensitizes a Large Fraction of Colorectal Cancer Cells to 5-Fluorodeoxyuridine and Raltitrexed but Not Fluorouracil.Mol Pharmacol2021
33739964Circulating tumor DNA in early-stage breast cancer: new directions and potential clinical applications.Clin Adv Hematol Oncol2021
33536276Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer.Clin Cancer Res2021
33529175Hierarchical tumor heterogeneity mediated by cell contact between distinct genetic subclones.J Clin Invest2021
34470810Correction: Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer.Clin Cancer Res2021
34390291Framework for Implementing and Tracking a Molecular Tumor Board at a National Cancer Institute-Designated Comprehensive Cancer Center.Oncologist2021
34040179The breast is yet to come: current and future utility of circulating tumour DNA in breast cancer.Br J Cancer2021
34092112Randomized Phase III Postoperative Trial of Platinum-Based Chemotherapy Versus Capecitabine in Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy: ECOG-ACRIN EA1131.J Clin Oncol2021
34290053A small-molecule activator of the unfolded protein response eradicates human breast tumors in mice.Sci Transl Med2021
34283806Systemic inhibition of PTPN22 augments anticancer immunity.J Clin Invest2021
33999652Updated Results of TBCRC026: Phase II Trial Correlating Standardized Uptake Value With Pathological Complete Response to Pertuzumab and Trastuzumab in Breast Cancer.J Clin Oncol2021
32259780Undetectable Tumor Cell-Free DNA in a Patient With Metastatic Breast Cancer With Complete Response and Long-Term Remission.J Natl Compr Canc Netw2020
31748278Sex Disparity Observed for Oncotype DX Breast Recurrence Score in Predicting Mortality Among Patients with Early Stage ER-Positive Breast Cancer.Clin Cancer Res2020
32259780Undetectable Tumor Cell-Free DNA in a Patient With Metastatic Breast Cancer With Complete Response and Long-Term Remission.J Natl Compr Canc Netw2020
31999303Variant Interpretation in Patients With Metastatic Breast Cancer-Reply.JAMA Oncol2020
31823098TrkA overexpression in non-tumorigenic human breast cell lines confers oncogenic and metastatic properties.Breast Cancer Res Treat2020
32277377Suppression of breast cancer metastasis and extension of survival by a new antiestrogen in a preclinical model driven by mutant estrogen receptors.Breast Cancer Res Treat2020
32644817Collaborative, Multidisciplinary Evaluation of Cancer Variants Through Virtual Molecular Tumor Boards Informs Local Clinical Practices.JCO Clin Cancer Inform2020
32847042Combined Targeting of Estrogen Receptor Alpha and Exportin 1 in Metastatic Breast Cancers.Cancers (Basel)2020
  • 1 - 50 of 340

Recommended Authors

Gabriele Zoppoli
University of Genoa and Ospedale Policlinico San Martino
Career Start Year 2008
Number of shared co-authors 10
Salvatore Piscuoglio
University of Basel
Career Start Year 2008
Number of shared co-authors 13
Barry S Taylor
Memorial Sloan Kettering Cancer Center
Career Start Year 2006
Number of shared co-authors 36
David W Cescon
Princess Margaret Cancer Centre
Career Start Year 2003
Number of shared co-authors 4
Siddhartha Deb
Olivia Newton-John Cancer Research Institute
Career Start Year 2002
Number of shared co-authors 0
Joshua Chuck Harrell
Virginia Commonwealth University
Career Start Year 2002
Number of shared co-authors 1
Darran P O'Connor
UCD Conway Institute, University College Dublin
Career Start Year 2001
Number of shared co-authors 1
Richard B Schwab
Department of Medicine and Moores Cancer Center, University of California San Diego
Career Start Year 2000
Number of shared co-authors 3
Luciano G Martelotto
Monash University
Career Start Year 2000
Number of shared co-authors 11
Kenna R Mills Shaw
The University of Texas MD Anderson Cancer Center
Career Start Year 1999
Number of shared co-authors 16
Charles Swanton
Francis Crick Institute
Career Start Year 1997
Number of shared co-authors 18
Jun Yao
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 3
Susan J Done
University Health Network
Career Start Year 1994
Number of shared co-authors 1
Carlos Caldas
Cancer Research UK Cambridge Institute, University of Cambridge
Career Start Year 1992
Number of shared co-authors 19
John M S Bartlett
University of Edinburgh
Career Start Year 1992
Number of shared co-authors 7
Levi A Garraway
Broad Institute of Harvard and MIT
Career Start Year 1991
Number of shared co-authors 24
Phillip A Futreal
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 20
Funda Meric-Bernstam
University of Texas MD Anderson Cancer Center
Career Start Year 1990
Number of shared co-authors 33
Katherine Stemke-Hale
MD Anderson Cancer Center, University of Texas
Career Start Year 1989
Number of shared co-authors 9
James M Ford
Stanford University
Career Start Year 1989
Number of shared co-authors 6
John W M Martens
Erasmus Medical Center (MC) Cancer Institute
Career Start Year 1989
Number of shared co-authors 12
Wei Zhang
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 14
William C Hahn
Broad Institute of MIT and Harvard, USA Dana-Farber Cancer Institute
Career Start Year 1987
Number of shared co-authors 7
Olli Kallioniemi
Karolinska Institute
Career Start Year 1984
Number of shared co-authors 9
Laura J Van't Veer
University of California San Francisco
Career Start Year 1984
Number of shared co-authors 23
Matthew Meyerson
Broad Institute
Career Start Year 1983
Number of shared co-authors 27
Alan Ashworth
UCSF Helen Diller Family Comprehensive Cancer Center
Career Start Year 1982
Number of shared co-authors 21
Edison T Liu
USA The Jackson Laboratory Cancer Center
Career Start Year 1982
Number of shared co-authors 5
Irene L Andrulis
University of Toronto
Career Start Year 1977
Number of shared co-authors 15
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Career Start Year 1976
Number of shared co-authors 41

Collaborators

Pedram Argani
The Johns Hopkins Hospital
Co-authored papers 23
Kurtis E Bachman
Co-authored papers 19
Julia A Beaver
Center for Drug Evaluation and Research
Co-authored papers 18
Justin Cidado
Oncology R&D
Co-authored papers 16
Vered Stearns
Co-authored papers 13
Antonio C Wolff
Co-authored papers 12
Bert Vogelstein
Co-authored papers 10
Kenneth W Kinzler
Co-authored papers 8
Nancy E Davidson
Co-authored papers 8
Mothaffar F Rimawi
Co-authored papers 6
Victor E Velculescu
Co-authored papers 4
Adrian V Lee
Co-authored papers 4
Sarah J Wheelan
National Human Genome Research Institute, National Institutes of Health
Co-authored papers 4
Brian W Simons
Center for Comparative Medicine, Baylor College of Medicine
Co-authored papers 4
Christopher D Gocke
Johns Hopkins University School of Medicine
Co-authored papers 4
Jorge S Reis-Filho
Memorial Sloan-Kettering Cancer Center
Co-authored papers 3
Charles Kent Osborne
Co-authored papers 3
Britta Weigelt
Memorial Sloan Kettering Cancer Center
Co-authored papers 3
Anna Maria Storniolo
Co-authored papers 3
Sanford D Markowitz
Co-authored papers 3
Ashani T Weeraratna
Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine
Co-authored papers 3
Nickolas Papadopoulos
Co-authored papers 3
Jeremy L Warner
Vanderbilt University Medical Center
Co-authored papers 3
Aparna Pallavajjala
Johns Hopkins University School of Medicine
Co-authored papers 3
Simina M Boca
Georgetown University Medical Center
Co-authored papers 3
Christian F Meyer
Johns Hopkins University School of Medicine
Co-authored papers 3
Susan G Hilsenbeck
Co-authored papers 3
Lisa A Carey
Co-authored papers 3
Phillip Buckhaults
University of South Carolina
Co-authored papers 3
Siân Jones
Co-authored papers 3
Release 1.2